Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-28
2006-11-28
O'Hara, Eileen B. (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S198100, C530S399000
Reexamination Certificate
active
07141548
ABSTRACT:
The present invention provides methods and compositions for preventing hyperinsulinemia that can result from therapeutic administration of growth hormone. The methods are carried out by imposing a restricted high-fat diet and/or by administering one or more drugs that lower serum lipids.
REFERENCES:
Cefalu, W. Exp. Biol. and Med. 226: 13-26, 2001.
Consensus Development Conference on Insulin Resistaance, Diabetes Care vol. 21, 310-314, 1998.
Nam et al., Int. J. of Obesity, 25: 1101-1107, 2001.
International Search Report Jun. 19, 2003.
Malmöff, K. et al., Eur J. Endo, vol. 146, pp. 121-128 (2002).
Malmöff, K. et al., Horm Metab Res, vol. 35, pp. 236-242 (2003).
Johansen, T. et al., Horm Metab Res, vol. 35, pp. 243-250 (2003).
Rizza, RA. et al., Diabetes, vol. 31, pp. 663-669 (1982) (Abstract).
Skaggs, SR. et al., Horm Res, vol. 35, pp. 19-24 (1991) (Abstract).
Snyder DK. et al., J Clin Endocrinol Metab., vol. 69, pp. 745-752 (1989) (Abstract).
Richelsen B. et al., Am J Physiol., vol. 266, pp. E211-E216 (1994).
Clemmons DR. et al., J Clin Endocrinal Metab, vol. 64, pp. 878-883 (1987.
Kim KR. et al., Horm Res, vol. 51, pp. 78-84 (1999).
Norrelund H. et al., Clin Endocrinol, vol. 52, pp. 305-312 (2000).
Lauterio TJ. et al., Metab Clin Exp, vol. 46, pp. 210-216 (1997).
Rasmussen MH. et al., J Clin Endocrinol Metab, vol. 80, pp. 1407-1415 (1995).
Johannsson et al., Journal of Clinical Endocrinology and Metabolism, vol. 83(3), pp. 727-734 (1997).
Segerlantz et. al., J Clin Endocrinol Metab, vol. 86, No. 12, pp. 5813-5818 (2001).
Nielsen et. al., Diabetes, vol. 50, pp. 2301-2308 (2001).
Piatti, et. al., J Clin Endocrinol Metab, vol. 84, No. 5, pp. 1658-1663 (1999).
Nam, et. al., Int J Obes, vol. 25, pp. 1101-1107 (2001).
Malmlöf, et. al., Horm Metab Res, vol. 35, pp. 236-242 (2003).
Sturiale, et. al., Horm Res, vol. 48, supplement, p. 190 (1997).
Metcalfe, et. al., Diabetologia, vol. 20, pp. 123-128 (1981).
Nielsen, S. Growth Horm IGF Res, vol. 12, pp. 425-433 (2002).
Johansen Thue
Malmlof Kjell
Bork Richard
Chandra Gyan
Green Reza
Novo Nordisk A S
O'Hara Eileen B.
LandOfFree
Prevention of hyperinsulinemia in subjects undergoing growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of hyperinsulinemia in subjects undergoing growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of hyperinsulinemia in subjects undergoing growth... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3697188